KRSNAA NSE filing

Krsnaa Diagnostics: Trading Window Closed from April 1, 2026 for FY26 Audited Results

The RealCase readLow impact Neutral

Krsnaa Diagnostics Limited will close its trading window from April 1, 2026, until 48 hours after the announcement of audited financial results for the quarter and fiscal year ending March 31, 2026. This measure aligns with SEBI's insider trading regulations.

Why it matters

This is a standard procedural announcement related to insider trading regulations and is a common practice for listed companies. It does not provide any new financial information or strategic updates that would significantly affect the company's valuation or investor sentiment.

The market read

The announcement is a routine regulatory disclosure regarding the closure of the trading window and does not contain any material information that would positively or negatively impact the company's stock.

Krsnaa Diagnostics Limited has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct.

The trading window will be shut from April 01, 2026, and will remain closed until 48 hours after the declaration of the Audited Financial Results for the quarter and the financial year ending on March 31, 2026. During this period, all Directors, Key Managerial Personnel, Designated Employees/persons, Promoters, and their immediate relatives are prohibited from trading in the company's securities, either directly or indirectly.

The company will separately intimate the date of the Board Meeting convened for the consideration and approval of these financial results.

Filing to action

What to do with a filing like this

Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under trading window disclosure. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.

View original filing